Qube Research & Technologies (QRT)
BPMC

Qube Research & Technologies (QRT)’s Blueprint Medicines BPMC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-66,275
Closed -$8.5M – 3580
2025
Q2 		$8.5M Sell
66,275
-270,876
-80% -$28.1M 0.01% 1389
2025
Q1 		$29.8M Sell
337,151
-12,939
-4% -$1.26M 0.03% 582
2024
Q4 		$30.5M Buy
350,090
+73,746
+27% +$6.75M 0.04% 542
2024
Q3 		$25.6M Buy
276,344
+144,296
+109% +$14.3M 0.04% 560
2024
Q2 		$14.2M Buy
132,048
+120,176
+1,012% +$12M 0.02% 769
2024
Q1 		$1.13M Buy
11,872
+3,715
+46% +$319K ﹤0.01% 2073
2023
Q4 		$752K Buy
+8,157
New +$529K ﹤0.01% 2079
2021
Q3 		– Sell
-2,529
Closed -$222K – 2231
2021
Q2 		$222K Buy
+2,529
New +$232K ﹤0.01% 1741
2021
Q1 		– Sell
-15,025
Closed -$1.69M – 1934
2020
Q4 		$1.69M Buy
+15,025
New +$1.58M 0.02% 683

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BPMC Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 66,275 shares — an estimated $8.5M sold.

Qube Research & Technologies (QRT) first reported a position in BPMC in Q4 2020 and held it in 9 quarters. The position peaked at $30.5M in Q4 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 66,275 Blueprint Medicines shares in Q3 2025, an estimated $8.5M.
  • Qube Research & Technologies (QRT) first reported a position in Blueprint Medicines in Q4 2020 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Blueprint Medicines position peaked at $30.5M in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.